Please provide your email address to receive an email when new articles are posted on . Adults with acromegaly who responded to treatment with an oral form of the somatostatin analogue octreotide ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved an oral form of the somatostatin analogue octreotide as a long-term maintenance therapy for ...
Available medical therapies for acromegaly are limited by moderate and variable efficacy, the need for life-long monthly intramuscular and/or deep subcutaneous depot, or thrice-daily subcutaneous ...
Presence of robust pipeline of drugs in clinical trials is the prime factor fueling market growth. For instance, in 2016, Mario Negri Institute for pharmacological research completed phase 2 clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results